欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population
ISSN号:0006-2952
期刊名称:Biochemical Pharmacology
时间:2012.3.3
页码:586-597
相关项目:克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
作者:
He, Jie-hua|Chen, Xing-gui|Chen, Xing-gui|Liang, Yong-ju|Liang, Yong-ju|Mi, Yan-jun|Mi, Yan-jun|To, Kenneth Kin Wah|To, Kenneth Kin Wah|
同期刊论文项目
克服ABC药物转运泵介导肿瘤细胞多药抗药性的新策略
期刊论文 12
同项目期刊论文
Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Ind
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance..
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-B
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of
Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vi
Axitinib Targeted Cancer Stem like Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibitin